Navigation Links
Published Data From e-HEALING Registry Demonstrate Good Clinical Outcomes With Low Incidence of Repeat Revascularization and Stent Thrombosis for OrbusNeich's Genous™ Stent
Date:2/22/2011

HONG KONG, Feb. 22, 2011 /PRNewswire/ -- OrbusNeich today announced that 12-month follow-up data from the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) registry published in the February issue of EuroIntervention demonstrated good clinical outcomes with low incidence of repeat revascularization and stent thrombosis (ST) for the company's Genous Stent.

Target vessel failure (TVF), defined as target vessel-related cardiac death or myocardial infarction (MI) and target vessel revascularization (TVR), was 8.4 percent at 12 months. The composite of death, MI or target lesion revascularization (TLR) occurred in 7.9 percent of the patients. TLR and ST were 5.7 percent and 1.1 percent, respectively.

"The good clinical outcomes for the Genous Stent in real-world use, especially the low incidence of stent thrombosis, demonstrate that the pro-healing approach of the Genous Stent is effective for a range of challenging patient groups," said Professor Sigmund Silber, M.D., Ph.D., of the Kardiologische Klinik Dr Muller, Munich, co-principal investigator and one of the lead authors of the publication. "As shown previously in several subset analyses of the e-HEALING registry, the Genous Stent produces exceptional outcomes in diabetic and elderly patients."

e-HEALING, a multi-center, worldwide prospective clinical registry conducted in 31 countries outside of the United States at 144 centers, included 4,939 patients with at least one lesion suitable for non-urgent percutaneous coronary intervention (PCI) and Genous Stent implantation. The mean age of the study population was 63 years, and 79 percent of patients were male. In addition, 25 percent of patients in the study cohort had diabetes mellitus, and 37 percent had a prior MI. On average, 1.3 lesions per patient were treated – 97.7 percent were de
'/>"/>

SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Caldolor® Rapid Infusion Shown to be Safe and Well Tolerated in Newly Published Clinical Study
2. CHAMPION Study Published in The Lancet
3. Data on DermTechs Non-invasive Test for Melanoma Are Published in the British Journal of Dermatology
4. New Published Study Finds Noninvasive Masimo PVI Accurately Predicts Fluid Responsiveness in Intensive Care Patients
5. Newly Published Data Demonstrates Caldolor® Significantly Reduces Pain and Morphine Use in Post-Operative Patients
6. First Five-Year Outcomes Published on CyberKnife Radiosurgery for Prostate Cancer
7. Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine
8. Topical China Industries Research Reports Published at MarketPublishers.com
9. New Topical Research Reports by iData Research Published by MarketPublishers.com
10. Published Study Concludes: Vented Baby Bottles Protect Essential Nutrients in Breast Milk and Formula
11. XIAFLEX® CORD II Study Published in The Journal of Hand Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... March 26, 2015  Becton, Dickinson and Company (NYSE: ... commence offers to exchange all validly tendered and accepted ... a wholly owned subsidiary of BD, for notes to ... below. A Registration Statement on Form S-4 (the "Registration ... was filed with the Securities and Exchange Commission ("SEC") ...
(Date:3/26/2015)... , 26. März 2015  Die ... wird vom 1. April 2015 an Zulassungsanträge für ... abgebenden Apotheken annehmen. Seit dem Start des ... Verband über 275 .pharmacy-Domainnamen zugelassen, die für ... Zeiten beantragt wurden. Die NABP startete .pharmacy ...
(Date:3/26/2015)... -- Gelesis , a clinical stage biotechnology ... to induce weight loss and improve glycemic control, ... of shares of convertible preferred stock for gross ... of approximately $4 million of outstanding convertible promissory ... to support the continued clinical development of its ...
Breaking Medicine Technology:Becton, Dickinson and Company to Commence Exchange Offers 2Becton, Dickinson and Company to Commence Exchange Offers 3Becton, Dickinson and Company to Commence Exchange Offers 4Becton, Dickinson and Company to Commence Exchange Offers 5Alle abgebenden Apotheken berechtigt, um ab dem 1. April 2015 .Pharmacy-Domainnamen zu beantragen 2Gelesis Closes $22M Equity Financing 2Gelesis Closes $22M Equity Financing 3
(Date:3/26/2015)... FL (PRWEB) March 26, 2015 ... the nation’s leading innovative specialty pharmacies, announces the ... position of Vice President of Pharmaceutical Relations. In ... beneficial connections with our pharmaceuticals partners and providing ... in support of BioPlus’ expansion. , “Over ...
(Date:3/26/2015)... In the key developed markets, the hypertension ... is set to decrease through 2020 at a negative CAGR ... expected up to 2017 at a 2.6% CAGR and a ... to the surging penetration of fixed-dose combination drugs like Azor, ... Benicar HCT, and Tekamlo), a hike in the prevalence population ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 Leading ... brand-new, state-of-the-art company website: http://www.metabolicnutrition.com . ... revamped website creates a user-friendly experience for consumers ... , The new, enhanced Metabolic Nutrition website ... about the company’s diverse line of products, conveniently ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 Zane Benefits, ... businesses, announced a new eBook, “The Comprehensive Guide To ... eBook, interviewing is the most important aspect of the ... they are hiring the right way, possibly resulting in ... be an arduous undertaking, yet it’s essential to the ...
(Date:3/26/2015)... 26, 2015 LinkToBanking, a Preferred ... names Tom Fleming as Chairman of the Board ... effective immediately. With their combined knowledge and ... industry, Mr. Fleming and Mr. Casares will provide ... to cannabis related businesses. , About Tom Fleming, ...
Breaking Medicine News(10 mins):Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 3Health News:Metabolic Nutrition Launches Sleek New Website with New Features and Enhanced Consumer Information 2Health News:Zane Benefits Announces: New eBook: The Comprehensive Guide To Interviewing For Your Small Business 2Health News:Tom Fleming named Chairman of the Board and Robert Casares as Vice-Chairman of the Board of LinkToBanking 2Health News:Tom Fleming named Chairman of the Board and Robert Casares as Vice-Chairman of the Board of LinkToBanking 3
... toll was so overwhelming that steam shovels were brought in ... trains commandeered to transport dead soldiers and priests could be ... threat of another flu pandemic looming in the not too ... preparations for it mortuary specialists are once more faced with ...
... babies much before the full term are administered steroids. ... the University of Adelaide , has found that subjecting ... babies by reducing potential breathing difficulties during delivery. ... babies from the Adelaide Women's and Children's Hospital. Research ...
... to introduce a system in which the GPs would be graded ... government to vote in favor for the new scheme of grading ... According to this the surgeries were to be inspected by doctors, ... one to three. It was a modification of the accreditation scheme. ...
... which is already running in a loss would have to pay ... are not in a position // to fulfil the commitment to ... health services. ,The trusts in the south of England ... ?20bn scheme under a deal with Japanese firm Fujitsu. But the ...
... Cheltenham Science Festival that it plans to send a ... //a research into the effects of low oxygen levels, ... for Aviation, Space and Extreme Environment Medicine at the ... will be conducting the research along with researchers around ...
... In a breakthrough move against HIV drug resistance, scientists have now ... that is the first in a new class of HIV drug ... Caspsid, a key viral protein from its precursor protein,this group of ... acid, and interferes with the production of the capsid conical ...
Cached Medicine News:Health News:What to do with the Dead if a Flu Outbreak Happens? 2Health News:Already Short Staffed And In Deficit NHS Fails To Supply Staff For IT Project 2Health News:Mount Everest to be Site of Research into Hypoxia 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: